Literature DB >> 6109022

Diuretic and beta-blocker in hypertension--then what?

L E Ramsay.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6109022      PMCID： PMC5373247     

Source DB:  PubMed          Journal:  J R Coll Physicians Lond        ISSN： 0035-8819


× No keyword cloud information.
  6 in total

1.  Treatment of essential hypertension and hypertension associated with renal impairment with pinacidil: a new vasodilator.

Authors:  E G Breen; D Mulhall; J A Keogh
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

2.  The lupus syndrome induced by hydralazine: a common complication with low dose treatment.

Authors:  H A Cameron; L E Ramsay
Journal:  Br Med J (Clin Res Ed)       Date:  1984-08-18

3.  Should the acetylator phenotype be determined when prescribing hydralazine for hypertension?

Authors:  L E Ramsay; J H Silas; J D Ollerenshaw; G T Tucker; F C Phillips; S Freestone
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

4.  "Third drug" trial: comparative study of antihypertensive agents added to treatment when blood pressure remains uncontrolled by a beta blocker plus thiazide diuretic.

Authors:  D McAreavey; L E Ramsey; L Latham; A D McLaren; A R Lorimer; J L Reid; J I Robertson; M P Robertson; R J Weir
Journal:  Br Med J (Clin Res Ed)       Date:  1984-01-14

5.  Pinacidil, a new vasodilator, in the treatment of mild to moderate essential hypertension.

Authors:  V D'Arcy; M Laher; D McCoy; P Sullivan; C H Walsh; M P Hickey
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

6.  Hydralazine and prazosin in the treatment of hypertension.

Authors:  M J Vandenburg; V L Sharman; P Wright; P J Drew; J N Barnes
Journal:  Br J Clin Pharmacol       Date:  1983-11       Impact factor: 4.335
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.